ARCHIVES

Ungerleider To Leave NCI For Theradex Corp.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Concepts Approved For $26.5Million In DCPC contracts, Including Heavy Smoker Program

February 1, 1985

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004

Fraumeni Appointed field Studies Chief

January 18, 1980

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011